Congress Speakers

  • Philip Home, UK  |  Congress Chairperson

    Philip Home, UK | Congress Chairperson

    Philip Home trained in medicine at Oxford University and Guy's Hospital, coming under the influence of Harry Keen, and thus gravitating into diabetes research. Continuing this research career in Newcastle upon Tyne, initially under the guidance of George Alberti, he has published over 390 papers ...
    Read More..
  • Richard Carr, UK

    Richard Carr, UK

    Richard has held drug discovery positions at Novo Nordisk and, currently, a regional medical affairs position at MSD. Richard also holds an honourary position at University College, London (UCL).  He was responsible for the initial proposal/discovery of the DPP4 inhibitor approach.
  • Antonio Ceriello, Spain

    Antonio Ceriello, Spain

    After earning his medical degree and specialty degree in diabetology and metabolic diseases at the University of Naples, Prof. Antonio Ceriello went on to hold a number of important research and professorship positions at prestigious scientific and academic institutions located in continental Europe, the U.S. and the U.K., ..
    Read More..
  • Richard Donnelly, UK

    Richard Donnelly, UK

    Richard Donnelly is currently Professor of Medicine in the University of Nottingham, UK and a Consultant Physician in Derby Teaching Hospitals NHS Foundation trust.  Previously he was a Fellow in Endocrinology at Stanford University, USA, and a Senior Lecturer in the University of Sydney.
  • David Fitchett, Canada

    David Fitchett, Canada

    Dr. David Fitchett graduated from Cambridge University UK, and continued his training at The Middlesex Hospital Medical School, The Brompton and Hammersmith Hospitals, London. He is a fellow of the American College of Cardiology, The European Society of Cardiology and of the Royal College of Physicians of Canada.

  • Nick Freemantle, UK

    Nick Freemantle, UK

    Nick Freemantle is Professor of Clinical Epidemiology and Biostatistics at University College London (UCL), UK, and Director of UCL’s Comprehensive Clinical Trials Unit, which undertakes high-quality, randomized trials and diagnostic studies in a real-world setting to inform clinical practice.

  • Francesco Giorgino, Italy

    Francesco Giorgino, Italy

    Francesco Giorgino is Professor of Endocrinology and Metabolism and Chairman of the Department of Emergency and Organ Transplantation at the University of Bari Aldo Moro, Bari, Italy. He is also Chief of the Division of Endocrinology at the University Hospital Policlinico Consorziale in Bari, Italy. 
  • Patricia Guyot, France

    Patricia Guyot, France

    Dr. Patricia Guyot has worked in various therapeutic areas such as diabetes, rheumatoid arthritis, COPD, migraine, and several oncology diseases. Her previous experience was primarily focused on network meta-analysis, indirect treatment comparison, population-adjusted indirect comparisons and on survival analyses. 
  • Jörg Huber, UK

    Jörg Huber, UK

    Jörg Huber is Professor of Health Sciences at University of Brighton and, since 1st Oct 2018, Director of the NIHR Research Design Service South East. 
  • Baruch Itzhak, Israel

    Baruch Itzhak, Israel

    Dr. Baruch Itzhak is a specialist in Family Medicine and Diabetologist at Clalit Health Services; Haifa district; Israel.  He was graduated for medicine at Tel-Aviv university in 1986. He received his medical degree of Family Medicine at the Technion faculty of medicine, Haifa in 1994.
  • Nigel Jones, UK

    Nigel Jones, UK

    Nigel Jones read Natural Sciences at Cambridge University.  He has worked in the pharmaceutical industry for 32 years, almost exclusively in clinical research.  Most of this time has been spent in assessing treatments for type 2 diabetes. 
  • Edoardo Mannucci, Italy

    Edoardo Mannucci, Italy

    Edoardo Mannucci grduated as a Medical Doctor at the University of Florence, Italy, in 1990, and he obtained the postgraduate degree of Endocrinology at the same University in 1990.
  • Sally Marshall, UK

    Sally Marshall, UK

    Professor Sally M Marshall was educated at University of Glasgow (BSc 1975, MB 1978, MD1990). She is currently Professor of Diabetes at the Institute of Cellular Medicine at Newcastle University, having previously held the position of Consultant Physician at Newcastle upon Tyne Hospitals NHS Trust.
  • David Ørsted, Denmark

    David Ørsted, Denmark

    David Ørsted works as a Global Medical Director for Novo Nordisk A/S. David joined Novo Nordisk in 2014 and is responsible for scientific communication of data from Novo Nordisk outcomes trials and activities within new therapy areas such as diabetic nephropathy and atherosclerosis. 

  • Ulrik Pedersen-Bjergaard, Denmark

    Ulrik Pedersen-Bjergaard, Denmark

    Ulrik Pedersen-Bjergaard is Chief Physician at the Department of Endocrinology and Nephrology, Nordsjællands Hospital Hillerød and Professor at the University of Copenhagen, Denmark.
  • Eberhard Standl, Germany

    Eberhard Standl, Germany

    Professor Eberhard Standl is Professor of Medicine, endocrinologist and angiologist at the Munich Diabetes Research Group e.V. at Helmholtz Centre. He has produced 627 original papers, review articles, textbook chapters and monographs.

  • Tina Vilsbøll, Denmark

    Tina Vilsbøll, Denmark

    Professor Vilsbøll has been involved in diabetes research since 1997, and in 2004 she established the Center for Diabetes Research at Gentofte Hospital, University of Copenhagen, Denmark.